Chondroitinase treatment following spinal contusion injury increases migration of oligodendrocyte progenitor cells

Experimental Neurology

Volumn 231, Issue 1, 2011, Pages 19-29

  Siebert, Justin R ^a   Stelzner, Dennis J ^a   Osterhout, Donna J ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

Axonal sprouting; Chondroitin sulfate proteoglycans; Chondroitinase ABC; GAP 43; Migration; Olig1; Oligodendrocyte progenitor cell; PDGF ; Proliferation; Spinal cord injury

Indexed keywords

N ACETYLGALACTOSAMINE 4 SULFATASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; IN VIVO STUDY; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NERVE SPROUTING; NEURAL STEM CELL; NONHUMAN; OLIGODENDROCYTE STEM CELL; PRIORITY JOURNAL; RAT; REMYELINIZATION; SPINAL CORD INJURY;

ANIMALS; CELL MOVEMENT; CHONDROITINASES AND CHONDROITIN LYASES; DISEASE MODELS, ANIMAL; FEMALE; NERVE REGENERATION; OLIGODENDROGLIA; RATS; RATS, LONG-EVANS; SPINAL CORD; SPINAL CORD INJURIES; STEM CELLS; TREATMENT OUTCOME;

EID: 79961024760     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.05.002     Document Type: Article

References (34)

1. Arvanian V.L., Schnell L., Lou L., Golshani R., Hunanyan A., Ghosh A., Pearse D.D., Robinson J.K., Schwab M.E., Fawcett J.W., Mendell L.M. Chronic spinal hemisection in rats induces a progressive decline in transmission in uninjured fibers to motor neurons. Exp. Neurol. 2009, 216:471-480.
2. Basso D.M., Beattie M.S., Bresnahan J.C., Anderson D.K., Faden A.I., Gruner J.A., Holford T.R., Hsu C.Y., Nobel L.J., Nockels R., Perot P.L., Salzman S.K., Young W. MASCIS evaluation of open field locomotor scores: effects of experience and teamwork on reliability. Multicenter Animal Spinal Cord Injury Study. J. Neurotrauma 1996, 13:343-359.
3. Baumann N., Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol. Rev. 2001, 81:871-910.
4. Bradbury E.J., Moon L.D.F., Popat R.J., King V.R., Bennett G.S., Patel P.N., Fawcett J.W., McMahon S.B. Chondroitinase ABC promotes function recovery after SCI. Nature 2002, 416:636-640.
5. Bunge R.P., Puckett W.R., Becerra J., Marcillo A., Quencer R.M. Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. Adv. Neurol. 1993, 59:75-89.
6. Busch S.A., Horn K.P., Cuascut F.X., Hawthorne A.L., Bai L., Miller R.H., Silver J. Adult NG2+ cells are permissive to neurite outgrowth and stabilize axons during macrophage-induced axonal dieback after spinal cord injury. J. Neurosci. 2010, 30:255-265.
7. Crowe M.J., Bresnahan J.C., Shuman S.L., Masters J.N., Beattie M.S. Apoptosis and delayed degenerations after spinal cord injury in rats and monkeys. Nat. Med. 1997, 3(1):73-76.
8. Fawcett J.W., Asher A.A. The glial scar and central nervous system repair. Brain Res. Bull. 1999, 49:227-391.
9. Fok-Seang J., Matthews G.A., French-Constant C., Trotter J., Fawcett J.W. Migration of oligodendrocyte precursors on astrocytes and meningeal cells. Dev. Biol. 1995, 171:1-15.
10. Franklin R.J.M., Gilson J.M., Blakemore W.F. Local recruitment of remyelinating cells in the repair of demyelination in the central nervous system. J. Neurosci. Res. 1997, 50:337-344.
11. Gerdes J., Schwab U., Lemke H., Stein H. Production of a mouse-monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer 1983, 31:13-20.
12. Gerdes J., Li L., Schlueter C., Duchrow M., Wohlenberg C., Gerlach C., Stahmer I., Kloth S., Brandt E., Flad H.D. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am. J. Pathol. 1991, 4:867-873.
13. Gruner J.A. A monitored contusion model of spinal cord injury in the rat. J. Neurotrauma 1992, 9:123-126. discussion 126-128.
14. Irvine K.A., Blakemore W.F. Remyelination protects axons from demyelination-associated axon degeneration. Brain 2008, 131:1464-1477.
15. Jones L.L., Margolis R.U., Tuszynski M.H. The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Exp. Neurol. 2003, 182:399-411.
16. Keirstead H.S., Levine J.M., Blakemore W.F. Response of the oligodendrocyte progenitor cell population (defined by NG2 labeling) to demyelination of the adult spinal cord. Glia 1998, 22:161-170.
17. Levine J.M., Reynolds R., Fawcett J.W. The oligodendrocyte precursor cell in health and disease. Trends Neurosci. 2001, 24:39-47.
18. Matsushima G.K., Morrel P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 2001, 11:107-116.
19. McTigue D.M., Tripathi R.B. The life, death, and replacement of oligodendrocytes in the adult CNS. J. Neurochem. 2008, 107:1-19.
20. Miller R.H. Regulation of oligodendrocyte development in the vertebrate CNS. Prog. Neurobiol. 2002, 67:451-467.
21. Norenberg M.D., Smith J., Marcillo A. The pathology of human spinal cord injury: defining the problems. J. Neurotrauma 2004, 21:429-440.
22. Popovich P.G., Wei P., Stokes B.T. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. Comp. Neurol. 1997, 377:443-464.
23. Pouly S., Becher B., Blain M., Antel J.P. Expression of a homologue of Rat NG2 on human microglia. Glia 1999, 27:259-268.
24. Profyris C., Cheema S.S., Zang D., Azari M., Boyle K., Petratos S. Degenerative and regenerative mechanisms governing spinal cord injury. Neurobiol. Dis. 2007, 15:415-436.
25. Remhal S., Hildebrand C. Relations between axons and oligodendroglial cells during initial remyelination. II. The individual axon. J. Neurocytol. 1990, 1:883-898.
26. Shuman S.L., Bresnahan J.C., Beattie M.S. Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats. J. Neurosci. Res. 1997, 50:798-808.
27. Tom V., Kadakia R., Santi L., Houle J.D. Administration of chondroitinase ABC rostral or caudal to a spinal cord injury site promotes anatomical but not functional plasticity. J. Neurotrauma 2009, 26:2323-2333.
28. Totoiu M.O., Keirstead H.S. Spinal cord injury is accompanied by chronic progressive demyelination. J. Comp. Neurol. 2005, 468:373-383.
29. Tripathi R., McTigue D.M. Prominent oligodendrocyte genesis along the border of spinal contusion lesions. Glia 2007, 55:698-711.
30. Yick L., Wu W., So K., Yip H.P., Shum D.K. Chondroitinase ABC promotes axonal regeneration of Clarke's neurons after spinal cord injury. Neuroreport 2000, 11:1063-1067.
31. Yick L., Cheung P., So K., Wu W. Axonal regeneration of Clarke's neurons beyond the spinal cord injury scar after treatment with chondroitinase ABC. Exp. Neurol. 2003, 182:160-168.
32. Yokoyama A., Sakamoto A., Kameda K., Imai Y., Tanaka J. NG2 Proteoglycan-expressing microglia as multipotent neural progenitors in normal and pathologic brains. Glia 2006, 53:754-768.
33. Zai L.J., Wrathall J.R. Cell proliferation and replacement following contusive spinal cord injury. Glia 2005, 50:247-257.
34. Zuo J., Neubauer D., Dyess K., Ferguson T.A., Muir D. Degradation of chondroitin sulfate proteoglycans enhances the neurite-promoting potential of spinal cord tissue. Exp. Neurol. 1998, 154:654-662.